Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A Defined Antigen Skin Test That Enables Implementation of BCG Vaccination for Control of Bovine Tuberculosis: Proof of Concept
by
Subramanian, Saraswathi
, Kapur, Vivek
, Jothivelu, Monika
, Srinivasan, Sreenidhi
, Ramaiyan Selvaraju, Kathiravan
, Vordermeier, Martin
, Shankar Balakrishnan, Sai
, Veerasami, Maroudam
, Kandasamy, Srinivasan
, Manomohan, Vandana
, Selladurai, Suganya
, Kathaperumal, Kumanan
, Gopal, Dhinakar Raj
, Bakker, Douwe
, Conlan, Andrew J. K.
in
BCG
/ bovine tuberculosis
/ DIVA
/ DST
/ specificity
/ Veterinary Science
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Defined Antigen Skin Test That Enables Implementation of BCG Vaccination for Control of Bovine Tuberculosis: Proof of Concept
by
Subramanian, Saraswathi
, Kapur, Vivek
, Jothivelu, Monika
, Srinivasan, Sreenidhi
, Ramaiyan Selvaraju, Kathiravan
, Vordermeier, Martin
, Shankar Balakrishnan, Sai
, Veerasami, Maroudam
, Kandasamy, Srinivasan
, Manomohan, Vandana
, Selladurai, Suganya
, Kathaperumal, Kumanan
, Gopal, Dhinakar Raj
, Bakker, Douwe
, Conlan, Andrew J. K.
in
BCG
/ bovine tuberculosis
/ DIVA
/ DST
/ specificity
/ Veterinary Science
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A Defined Antigen Skin Test That Enables Implementation of BCG Vaccination for Control of Bovine Tuberculosis: Proof of Concept
by
Subramanian, Saraswathi
, Kapur, Vivek
, Jothivelu, Monika
, Srinivasan, Sreenidhi
, Ramaiyan Selvaraju, Kathiravan
, Vordermeier, Martin
, Shankar Balakrishnan, Sai
, Veerasami, Maroudam
, Kandasamy, Srinivasan
, Manomohan, Vandana
, Selladurai, Suganya
, Kathaperumal, Kumanan
, Gopal, Dhinakar Raj
, Bakker, Douwe
, Conlan, Andrew J. K.
in
BCG
/ bovine tuberculosis
/ DIVA
/ DST
/ specificity
/ Veterinary Science
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A Defined Antigen Skin Test That Enables Implementation of BCG Vaccination for Control of Bovine Tuberculosis: Proof of Concept
Journal Article
A Defined Antigen Skin Test That Enables Implementation of BCG Vaccination for Control of Bovine Tuberculosis: Proof of Concept
2020
Request Book From Autostore
and Choose the Collection Method
Overview
In most low- and middle-income countries (LMICs), bovine tuberculosis (bTB) remains endemic due to the absence of control programs. This is because successful bTB control and eradication programs have relied on test-and-slaughter strategies that are socioeconomically unfeasible in LMICs. While Bacillus Calmette-Guérin (BCG) vaccine-induced protection for cattle has long been documented in experimental and field trials, its use in control programs has been precluded by the inability to differentiate BCG-vaccinated from naturally infected animals using the OIE-prescribed purified protein derivative (PPD)-based tuberculin skin tests. In the current study, the diagnostic specificity and capability for differentiating infected from vaccinated animals (DIVA) of a novel defined antigen skin test (DST) in BCG-vaccinated (Bos taurus ssp. taurus x B. t. ssp. indicus) calves were compared with the performance of traditional PPD-tuberculin in both the skin test and in vitro interferon-gamma release assay (IGRA). The IFN-γ production from whole blood cells stimulated with both PPDs increased significantly from the 0 week baseline levels, while DST induced no measurable IFN-γ production in BCG-vaccinated calves. None of the 15 BCG-vaccinated calves were reactive with the DST skin test (100% specificity; one-tailed lower 95% CI: 82). In contrast, 10 of 15 BCG-vaccinated calves were classified as reactors with the PPD-based single intradermal test (SIT) (specificity in vaccinated animals = 33%; 95% CI: 12, 62). Taken together, the results provide strong evidence that the DST is highly specific and enables DIVA capability in both skin and IGRA assay format, thereby enabling the implementation of BCG vaccine-based bTB control, particularly in settings where test and slaughter remain unfeasible.In most low- and middle-income countries (LMICs), bovine tuberculosis (bTB) remains endemic due to the absence of control programs. This is because successful bTB control and eradication programs have relied on test-and-slaughter strategies that are socioeconomically unfeasible in LMICs. While Bacillus Calmette-Guérin (BCG) vaccine-induced protection for cattle has long been documented in experimental and field trials, its use in control programs has been precluded by the inability to differentiate BCG-vaccinated from naturally infected animals using the OIE-prescribed purified protein derivative (PPD)-based tuberculin skin tests. In the current study, the diagnostic specificity and capability for differentiating infected from vaccinated animals (DIVA) of a novel defined antigen skin test (DST) in BCG-vaccinated (Bos taurus ssp. taurus x B. t. ssp. indicus) calves were compared with the performance of traditional PPD-tuberculin in both the skin test and in vitro interferon-gamma release assay (IGRA). The IFN-γ production from whole blood cells stimulated with both PPDs increased significantly from the 0 week baseline levels, while DST induced no measurable IFN-γ production in BCG-vaccinated calves. None of the 15 BCG-vaccinated calves were reactive with the DST skin test (100% specificity; one-tailed lower 95% CI: 82). In contrast, 10 of 15 BCG-vaccinated calves were classified as reactors with the PPD-based single intradermal test (SIT) (specificity in vaccinated animals = 33%; 95% CI: 12, 62). Taken together, the results provide strong evidence that the DST is highly specific and enables DIVA capability in both skin and IGRA assay format, thereby enabling the implementation of BCG vaccine-based bTB control, particularly in settings where test and slaughter remain unfeasible.
Publisher
Frontiers Media S.A
Subject
This website uses cookies to ensure you get the best experience on our website.